Where is the live CopyMark page for USPTO serial 79013806?

The live record is at https://getcopymark.com/trademark/79013806. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns Serial No. 79013806?

According to the public USPTO record for serial number 79013806, the listed owner(s) include: YANGZIJIANG YAOYE JITUAN YOUXIAN GONGSI, YANGZIJIANG YAOYE JITUAN YOUXIAN GONGSI, YANGZIJIANG YAOYE JITUAN YOUXIAN GONGSI.

What is USPTO serial number 79013806?

Serial number 79013806 is the USPTO application identifier for the mark Serial No. 79013806. It is used to track examination, publication, and registration of this trademark.

What is the current status of Serial No. 79013806?

Serial No. 79013806 (79013806) currently shows USPTO status code 404 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover Serial No. 79013806?

The public record lists International Classes: 005. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: Serial No. 79013806 Serial# 79013806 | status 404; last event DENC | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 79013806?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Goods and services

Class	Description	Status	First use
005	Pharmaceutical preparations for the treatment of thrombi, hypertension and cold; chemico-pharmaceutical preparations for the treatment of infective diseases, peptic ulcer, depression, and osteoporosis; contrast media for use with radiological equipment; pharmaceutical preparations in the form of capsule for the treatment of blood-fat abnormity, coronary heart disease and endocrinosis; pharmaceutical preparations, namely, medicines for human purposes for the treatment of cardiovascular and cerebrovascular disease, diarrhea, hepatitis and pediatric anorexia; medicinal drinks for the treatment of adiposity, deficiency disease, disorder of aqueous electrolytical metabolization and imbalance of acid and alkali; pharmaceutical preparations for injection for the treatment of angina, arrhythmia and tumour; pharmaceutical preparations in the form of ointment and paste for the treatment of hemostasia, anaesthesia and for the cure of ache and acesodyne; Chinese patent medicines for the treatment of gastralgia, pectoral pain with stuffiness, and apoplexy; pharmaceutical preparations in the form of bolus, pellet or pill for the treatment of anemia, nephropathy and insomnia; pharmaceutical preparations in the form of medical adhesive plaster; biochemical medicines for the treatment of infective disease and increase of intracranial pressure; pharmaceutical preparations made from blood for the treatment of anemia, leucocythemia and hematoblastic disease; pharmaceutical preparations in the form of glue pill for the treatment of diabetes, hepatitis and gastricism; medicated wine and spirit for medical purposes for the improvement of immunity and local micro-circulation; depuratives for the body; wadding for medical purposes, namely soft raw cotton and felt for packing, lining casts and limb prosthesis; medical preparations for facilitate teething; made-up medicines that immerse raw medicines into alcohol and dissolve chemical medicines into alcohol to take effect together for the improvement of local micro-circulation and for the cure of ache; made-up medicines that dissolve water-soluble raw medicines into water to take effect together for the treatment of nephritis, sexual function handicap and bronchitic asthma; medicines in the form of tablets for the treatment of hypertension, heart failure and arrhythmia; material as medicines, namely, pharmaceutical preparations for the treatment of tumour, infective diseases and phthisis; analgesics, eye-wash, eye-drops, dietetic food preparations adapted for medical purposes; additives to fodder for medical purposes; vermin destroying preparations	SECTION 71 - CANCELLED	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Jan 21, 2016	DENC	NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED	—
Jan 21, 2016	DETH	DEATH OF INTERNATIONAL REGISTRATION	—
Jun 5, 2015	INNT	TOTAL INVALIDATION PROCESSED BY THE IB	—
Oct 3, 2014	XXSS	GENERIC MADRID TRANSACTION SENT TO IB	—
Oct 3, 2014	XXCR	GENERIC MADRID TRANSACTION CREATED	—
May 20, 2014	INTR	TOTAL INVALIDATION OF REG EXT PROTECTION CREATED	—
Sep 20, 2013	C71T	CANCELLED SECTION 71	—
May 2, 2008	FINO	FINAL DECISION TRANSACTION PROCESSED BY IB	—
Aug 9, 2007	FICS	FINAL DISPOSITION NOTICE SENT TO IB	—
Aug 9, 2007	FIMP	FINAL DISPOSITION PROCESSED	—
Aug 1, 2007	FICR	FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB	—
Jan 2, 2007	R.PR	REGISTERED-PRINCIPAL REGISTER	Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 17, 2006	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 27, 2006	NPUB	NOTICE OF PUBLICATION	—
Sep 9, 2006	PREV	LAW OFFICE PUBLICATION REVIEW COMPLETED	—
Sep 6, 2006	ALIE	ASSIGNED TO LIE	—
Aug 16, 2006	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Aug 7, 2006	ACEC	AMENDMENT FROM APPLICANT ENTERED	—
Jul 27, 2006	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Jul 27, 2006	MAIL	PAPER RECEIVED	—
Jun 16, 2006	CNRT	NON-FINAL ACTION MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 31, 2006	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 31, 2006	ZZZX	PREVIOUS ALLOWANCE COUNT WITHDRAWN	—
May 19, 2006	PBCR	WITHDRAWN FROM PUB - OG REVIEW QUERY	—
Apr 25, 2006	PREV	LAW OFFICE PUBLICATION REVIEW COMPLETED	—
Apr 21, 2006	ALIE	ASSIGNED TO LIE	—
Apr 21, 2006	ALIE	ASSIGNED TO LIE	—
Apr 18, 2006	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Apr 14, 2006	ACEC	AMENDMENT FROM APPLICANT ENTERED	—
Mar 29, 2006	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Mar 29, 2006	MAIL	PAPER RECEIVED	—
Feb 24, 2006	RFNP	REFUSAL PROCESSED BY IB	—
Feb 3, 2006	RFCS	NON-FINAL ACTION MAILED - REFUSAL SENT TO IB	—
Feb 3, 2006	RFCR	NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW	—
Feb 2, 2006	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 26, 2006	DOCK	ASSIGNED TO EXAMINER	—
Sep 16, 2005	NWAP	NEW APPLICATION ENTERED	—
Sep 15, 2005	REPR	SN ASSIGNED FOR SECT 66A APPL FROM IB	—

Serial No. 79013806